Lexicon Pharmaceuticals, Inc.
NASDAQ: LXRX
$1.33
-$0.03 (-2.2%)
Closing price October 23, 2020
24/7 Wall St. has compiled a list of some speculative biotech plays that could see gains of up to 300% in the coming months.
2 months ago
Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2 diabetes.
3 months ago
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
1 year ago
Last Updated: 8 months ago
Lexicon Pharma shares were absolutely crushed on Monday after it was announced that Sanofi would be ending its partnership with the firm.
1 year ago
Last Updated: 8 months ago
Lexicon shares jumped on Friday after the European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion on the Marketing Authorization of Zynquista...
1 year ago
Last Updated: 8 months ago
Vodafone, Lexicon Pharmaceuticals, Amneal Pharmaceuticals, and Maiden Holding had all posted new 52-week lows by noon Friday.
1 year ago
Last Updated: 8 months ago
Immunomedics, Signet Jewelry, Nautilus, and Lexicon Pharmaceuticals had all posted new 52-week lows by noon Friday.
1 year ago
Last Updated: 8 months ago
Lexicon shares fell on Friday after the FDA voted to approve the firm’s type 1 diabetes treatment. Although the result from this committee was mixed, it seems to be a case of sell the news.
1 year ago
Last Updated: 8 months ago
Here, 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
2 years ago
Last Updated: 7 months ago
Here 24/7 Wall St. has included a calendar of a few of companies to watch for in the coming week and the rest of June.
2 years ago
Last Updated: 9 months ago
The top analyst upgrades, downgrades and other research calls from Monday include American Electric Power, American Water Works, BHP Billiton, Boeing, Costco, Crocs, Dollar General, McDonald's and...
2 years ago
Last Updated: 9 months ago
These top picks from Wedbush offer varying degrees of risk and upside. The fact that they are not crowded momentum plays makes them far more attractive for the rest of 2017 and into next year.
3 years ago
Last Updated: 9 months ago
Equifax, New York REIT, Opko, and Lexicon Pharma all posted new 52-week lows Thursday.
3 years ago
Last Updated: 9 months ago
Hewlett Packard Enterprise, Equifax, New York REIT, and Lexicon Pharmaceuticals all posted new 52-week lows on Wednesday.
3 years ago
Last Updated: 9 months ago
The top analyst upgrades, downgrades and other research calls from Monday Adobe, Alibaba, Apple, Pandora, Vodafone, Cigna and Lexicon Pharma.
3 years ago
Last Updated: 7 months ago